艾布魯(301259.SZ):預中標洞口縣毓蘭鎮等9個建制鎮污水處理特許經營項目
格隆匯5月26日丨艾布魯(301259.SZ)公佈,近日,中國湖南政府採購網公佈了“洞口縣毓蘭鎮等9個建制鎮污水處理特許經營項目公開招標中標公吿”,公示湖南艾布魯環保科技股份有限公司為該項目的預中標供應商。
項目總投資約2.42億元,其中建築工程投資1.66億元,設備購置費投資3538.11萬元,安裝工程費用投資318.48萬元,其他費用投資3707.56萬元。
項目擬在洞口縣範圍內毓蘭鎮等九個建制鎮進行污水處理廠及管網等配套設施建設及運營。其中污水處理廠近期設計總規模 5070m3/d,遠期總規模9540m3/d,本次新建近期規模;新建配套管網設施工程145.121km。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.